Sponsor

This activity is jointly sponsored by the University of Cincinnati, Medical Learning Institute, Inc. (a non-profit medical accreditation company), and Center of Excellence Media, LLC.

Target Audience

This activity was developed for physicians, nurses, pharmacists, and other healthcare professionals practicing in a managed care environment.

Learning Objectives

Upon completion of this activity, the participant will be able to:

• Explain the impact of key data from the American Academy of Neurology 2010 on payers and pharmacists
• Assess potential clinical, business, and regulatory changes in multiple sclerosis medicine
• Discuss patient-centered, value-based care in multiple sclerosis medicine

Commercial Support Acknowledgment

This activity is supported by an educational grant from Bayer.

Instructions for Credit

There is no fee for this activity. After reading this CME/CE activity in its entirety, participants must complete the posttest and evaluation. The posttest and evaluation can be completed online at www.mlicme.org/p10043.html. Upon completion of the evaluation and scoring 70% or better on the posttest, you will immediately receive your certificate online. If you do not achieve a score of 70% or better on the posttest, you will be asked to take it again. Please retain a copy of the certificate for your records.

Physician Credit Designation

The University of Cincinnati designates this activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians should only claim credit commensurate with the extent of their participation in this activity.

Registered Nurse Designation

Medical Learning Institute, Inc.

Provider approved by the California Board of Registered Nursing, Provider Number 15106, for 1 contact hour.

Pharmacists Designation

Medical Learning Institute, Inc., is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Completion of this activity provides for 1.0 contact hour (0.1 CEU) of continuing education credit. The universal activity number for this activity is 0468-9999-10-039-H01-P.

For questions regarding the accreditation of this activity, please contact Medical Learning Institute, Inc., at 609-333-1693 or cgusack@mlicme.org.

Disclosures

Before the activity, all faculty will disclose the existence of any financial interest and/or relationship(s) they might have with the manufacturer(s) of any commercial product(s) to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speaker’s bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. 

Jack S. Burks, MD, is on the Speaker’s Bureau for Bayer, Biogen Idec, Eli Lilly, and Wyeth, and is a Consultant to Bayer, Discovery Chicago, and Eli Lilly.

Alice Goodman has nothing to disclose.

The University of Cincinnati, the associates of Medical Learning Institute, Inc., the accredited provider for this activity, and Center of Excellence Media, LLC, do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/CE activity for any amount during the past 12 months.

Disclaimer

The information provided in this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. Trade names used in this supplement are for the learner’s reference only. No promotion of or bias toward any product should be inferred.

Estimated time to complete activity: 1 hour

Initial Release Date: July 15, 2010.

Expiration Date: July 15, 2011.